CWP
INSM icon

Concord Wealth Partners’s Insmed INSM Stock Holding History

Concord Wealth Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107 Buy
+1
New +$121 ﹤0.01% 860
2026
Q1 		– Sell
-1
Closed -$174 – 483
2025
Q4 		$174 Hold
1
– – ﹤0.01% 808
2025
Q3 		$144 Hold
1
– – ﹤0.01% 798
2025
Q2 		$101 Buy
+1
New +$76 ﹤0.01% 834
2021
Q1 		– Sell
-55
Closed -$2K – 1030
2020
Q4 		$2K Buy
+55
New +$2.01K ﹤0.01% 534

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Concord Wealth Partners's INSM Position: Q2 2026 in Review

Concord Wealth Partners opened a new position in Insmed (INSM) in Q2 2026: 1 share worth $107. The stake represents ﹤0.01% of the portfolio and ranks #860 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in INSM as recently as Q4 2025.

Concord Wealth Partners first reported a position in INSM in Q4 2020 and has held it in 5 quarters since. The position peaked at $2K in Q4 2020. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Concord Wealth Partners held 1 share of Insmed worth $107 as of Q2 2026.
  • Insmed was a new Concord Wealth Partners position in Q2 2026.
  • Insmed made up ﹤0.01% of Concord Wealth Partners's portfolio in Q2 2026, its #860 holding.
  • Concord Wealth Partners first reported a position in Insmed in Q4 2020 and has held it in 5 quarters since.
  • Concord Wealth Partners's Insmed position peaked at $2K in Q4 2020.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.